Literature DB >> 22652506

Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.

John M Nolan1, Mukunda C Akkali, James Loughman, Alan N Howard, Stephen Beatty.   

Abstract

This study was designed to investigate the impact of macular carotenoid supplementation on the spatial profile of macular pigment (MP) in subjects where the profile does not exhibit the typical central peak (i.e. peaked MP at foveal epicentre). Thirty one healthy subjects with such atypical MP spatial profiles were assigned to one of three intervention groups: Group 1: (n = 10), 20 mg/day lutein (L), 2 mg/day zeaxanthin (Z); Group 2: (n = 10), 10 mg/day meso-zeaxanthin (MZ), 10 mg/day L, 2 mg/day Z; Group 3: (n = 10), 17 mg/day MZ, 3 mg/day L, 2 mg/day Z. Subjects were instructed to take one capsule daily over an 8-week period. MP at 0.25°, 0.5°, 1°, 1.75° and 3° was measured using customized-heterochromatic flicker photometry at baseline, four weeks and 8 weeks. Over the study period, we report no statistically significant increase in MP at any eccentricity in Group 1 (p > 0.05, for all eccentricities). There was a trend towards an increase in MP at all eccentricities in Group 2, with a significant increase found at 0.25° and 0.50° (p = 0.000 and p = 0.016, respectively). There was a statistically significant increase evident in MP at 0.25° in Group 3 (p = 0.005), but at no other eccentricity (p > 0.05, for all other). We report that the typical central peak of MP can be realised in subjects with atypical spatial profiles, following supplementation with a preparation containing all three macular carotenoids, but not with a supplement lacking MZ. The implications of our findings, in terms of visual performance and/or a (photo)-protective effect, warrant additional study.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652506     DOI: 10.1016/j.exer.2012.05.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  22 in total

1.  Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.

Authors:  David I Thurnham; John M Nolan; Alan N Howard; Stephen Beatty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-10-14       Impact factor: 3.117

2.  The macular pigment optical density spatial profile and increasing age.

Authors:  Raymond O Beirne
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-01       Impact factor: 3.117

Review 3.  Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.

Authors:  Jennifer R Evans; John G Lawrenson
Journal:  Cochrane Database Syst Rev       Date:  2017-07-31

Review 4.  What is meso-zeaxanthin, and where does it come from?

Authors:  J M Nolan; K Meagher; S Kashani; S Beatty
Journal:  Eye (Lond)       Date:  2013-05-24       Impact factor: 3.775

5.  Genetic determinants of macular pigments in women of the Carotenoids in Age-Related Eye Disease Study.

Authors:  Kristin J Meyers; Elizabeth J Johnson; Paul S Bernstein; Sudha K Iyengar; Corinne D Engelman; Chitra K Karki; Zhe Liu; Robert P Igo; Barbara Truitt; Michael L Klein; D Max Snodderly; Barbara A Blodi; Karen M Gehrs; Gloria E Sarto; Robert B Wallace; Jennifer Robinson; Erin S LeBlanc; Gregory Hageman; Lesley Tinker; Julie A Mares
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

6.  Genetic evidence for role of carotenoids in age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS).

Authors:  Kristin J Meyers; Julie A Mares; Robert P Igo; Barbara Truitt; Zhe Liu; Amy E Millen; Michael Klein; Elizabeth J Johnson; Corinne D Engelman; Chitra K Karki; Barbara Blodi; Karen Gehrs; Lesley Tinker; Robert Wallace; Jennifer Robinson; Erin S LeBlanc; Gloria Sarto; Paul S Bernstein; John Paul SanGiovanni; Sudha K Iyengar
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-29       Impact factor: 4.799

Review 7.  Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease.

Authors:  Paul S Bernstein; Binxing Li; Preejith P Vachali; Aruna Gorusupudi; Rajalekshmy Shyam; Bradley S Henriksen; John M Nolan
Journal:  Prog Retin Eye Res       Date:  2015-11-02       Impact factor: 21.198

8.  The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.

Authors:  Christopher J Hammond; S H Melissa Liew; Frederik J Van Kuijk; Stephen Beatty; John M Nolan; Tim D Spector; Clare E Gilbert
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-26       Impact factor: 4.799

9.  Effects of lutein and docosahexaenoic Acid supplementation on macular pigment optical density in a randomized controlled trial.

Authors:  Alfredo García-Layana; Sergio Recalde; Angel Salinas Alamán; Patricia Fernández Robredo
Journal:  Nutrients       Date:  2013-02-15       Impact factor: 5.717

10.  Feasibility Study of a Docosahexaenoic Acid-Optimized Nutraceutical Formulation on the Macular Levels of Lutein in a Healthy Mediterranean Population.

Authors:  Vicente Zanón-Moreno; Joan C Domingo Pedrol; Silvia M Sanz-González; Jorge Raga-Cervera; Juan Salazar-Corral; Maria Dolores Pinazo-Durán
Journal:  Ophthalmic Res       Date:  2020-06-16       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.